2018
DOI: 10.1016/j.ahj.2018.02.012
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics and long term outcomes of patients with acute coronary syndromes due to culprit left main coronary artery disease treated with percutaneous coronary intervention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 23 publications
0
9
0
Order By: Relevance
“…Sim et al found acute MI patients with a culprit LMCA having higher inhospital mortality than patients with nonculprit LMCA, while 1-year clinical outcomes were similar [22]. In a larger observational study [23], long-term survival rates (median follow-up time was 6.3 years) were similar between STEMI patients and UA/NSTEMI patients due to unprotected LMCA disease.…”
Section: Discussionmentioning
confidence: 94%
“…Sim et al found acute MI patients with a culprit LMCA having higher inhospital mortality than patients with nonculprit LMCA, while 1-year clinical outcomes were similar [22]. In a larger observational study [23], long-term survival rates (median follow-up time was 6.3 years) were similar between STEMI patients and UA/NSTEMI patients due to unprotected LMCA disease.…”
Section: Discussionmentioning
confidence: 94%
“…Out of the seven patients treated with ECMO, five (71%) survived to the 1-year follow-up. Currently, in several studies, ECMO or TandemHeart support was used, but the comparison of mortality rates is hampered as the inclusion criteria and prevalence of cardiogenic shock varies strongly [ 1 , 13 , 20 , 24 , 29 , 31 , 37 , 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…The major findings of this analysis in patients presenting with MVD and acute MI complicated by CS are the following: (1) a CL located in the LM or pLAD vs other coronary segments is associated with worse short- and long-term outcomes, and (2) a strategy of CL-PCI with optional staged revascularization of non-CL as compared with immediate MV-PCI resulted in a reduced risk of death or kidney replacement therapy at 30 days regardless of CL location and in a 1-year mortality benefit in patients with LM/pLAD CL location. In consensus with these findings, previous studies documented worse outcomes associated with LM/pLAD CL location compared with OCLL . In hemodynamically stable patients, CL location in the LM or pLAD has been shown to be associated with higher risk of target lesion revascularization and MI .…”
Section: Discussionmentioning
confidence: 99%